Lonidamine and human lymphoblastoid alpha interferon in metastatic cancer: a phase I study.
Cancer Invest
; 8(5): 505-8, 1990.
Article
em En
| MEDLINE
| ID: mdl-2265373
ABSTRACT
The purpose of this study was to test the qualitative and quantitative toxicity of lonidamine (L) and alpha-interferon (IFN alpha) when used together, and to observe any apparent synergistic activity in conventionally untreatable measurable metastatic cancer. Eleven patients (8 males and 3 females) were enrolled. There was one response seen as measured by conventional criteria. There is no evidence that these agents are additive at this dose schedule, nor is their apparent synergistic activity.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Interferon Tipo I
/
Indazóis
/
Neoplasias
Tipo de estudo:
Qualitative_research
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cancer Invest
Ano de publicação:
1990
Tipo de documento:
Article
País de afiliação:
Canadá